A drug that treats Type 2 diabetes could become the best-selling medication in history if approved by the U.S. Food and Drug Administration to treat obesity. The drug, tirzepatide, was created by Eli ...
Estimates released last month by the Connecticut Department of Public Health show that 10.7% of Connecticut adults had diagnosed diabetes in 2022, down from 10.8% the previous year but up from 8.3% in ...
As the first dual SGLT1/SGLT2 inhibitor developed for use in diabetes, Lexicon’s sotagliflozin has tantalizing potential. But getting the pill to pass muster with the FDA has been problematic. The ...
About 1 in 3 U.S. Teens Now Have Prediabetes, New CDC Data Shows FRIDAY, July 11, 2025 (HealthDay News) — A new government estimate shows that nearly 1 in 3 U.S. teens have prediabetes, putting them ...
In its first evaluation of real-world data derived from its FreeStyle Libre continuous glucose monitor in people with Type 2 diabetes, Abbott found that the system was able to significantly reduce ...
More than 30 percent of American teenagers were considered prediabetic in 2023, according to recent data from the Centers for Disease Control and Prevention (CDC). The CDC calculated there were 8.4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback